Since the COVID-19 vaccines were authorized by the FDA, one of the big questions has been how well they prevent transmission of the COVID-19 even among those who have been vaccinated. The clinical trials used disease — an infection with symptoms — as the endpoint because stopping severe disease and death was the most important priority. In addition, it’s very difficult to develop a vaccine that creates sterilizing immunity, the type of immunity that prevents infection — the virus’s ability to enter cells and begin replicating. Continue reading
I’ve written before about the importance of finding not just any expert but one with detailed expertise in the specific area you need when covering a study. In that context, it was with COVID-19, but the same holds true with any research. If you’re covering a nutrition study, calling up any nutritionist to get an outside opinion does not ensure you are getting a fully informed opinion from someone familiar with the evidence. You need a nutrition researcher who is very familiar with the specific research in the paper. Continue reading
Just a day after AstraZeneca announced long-awaited interim results from its U.S. phase 3 trial earlier this week, the company again became mired in controversy about what’s going on with its vaccine.
The trial’s Data and Safety Monitoring Board (DSMB) — a group of independent experts who monitor the safety and efficacy of a drug or intervention during a trial — sent a memo to the company and government health officials, including the National Institutes of Health (NIH), contesting the company’s portrayal of its vaccine’s efficacy. Continue reading
Journalists interested in building careers reporting on science, health and the environment are eligible to apply for new cross-cutting fellowships designed to provide training, networking, mentoring, new sources and story ideas, while allowing them to stay at their jobs.
The National Science-Health-Environment Reporting Fellowships are a first-ever collaboration of the Council for the Advancement of Science Writing (CASW), the Association of Health Care Journalists (AHCJ), and the Society of Environmental Journalists (SEJ). The year-long fellowships are open to early-career journalists interested in covering any or all of the three fields.
Health Journalism 2021 is scheduled for Oct. 28-31 in Austin, Texas. The downtown Hilton Austin will serve as the main conference site.
“We have been working closely with the hotel in Austin to secure these new dates for Health Journalism 2021,” said AHCJ Executive Director Andrew Smiley. Continue reading